DISCO PHARMACEUTICALS Logo (EUIPO, 12/20/2023)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark DISCO PHARMACEUTICALS was filed as Figurative mark on 12/20/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/10/2024.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#One sphere #Letters containing written or typographical matter
| Trademark form | Figurative mark |
| File reference | 018966351 |
| Application date | December 20, 2023 |
| Publication date | February 1, 2024 |
| Entry date | May 10, 2024 |
| Expiration date | December 20, 2033 |
Trademark owner
Gottfried-Hagen-Straße 60-62
51105 Köln
DE
51105 Köln
DE
Trademark representatives
Nymphenburger Str. 12
80335 München
DE
goods and services
1
Chemicals and biomolecules, in particular biological macromolecules, for industrial, scientific purposes
5
Chemicals for medical use; Pharmaceuticals; Immunostimulatory compositions; Vaccines; Adjuvant immunostimulants; Pharmaceuticals and medicines, in particular based on biological macromolecules, for treating neurological, neuromuscular, neurodegenerative or cardiovascular diseases, for treating infectious diseases, allergies, autoimmune disorders or tumours, for treating metabolic disorders or for treating inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapy
42
SCIENTIFIC AND TECHNOLOGICAL SERVICES AND RESEARCH SERVICES, IN PARTICULAR FOR IDENTIFYING AND CHARACTERIZING BIOLOGICAL MACROMOLECULES; Development of pharmaceuticals or vaccines; Conducting of and scientific support for preclinical or clinical studies
44
Medical services, in particular for therapeutic and preventative treatment of tumours, infectious diseases, autoimmune disorders and allergies, for treating inherited genetic diseases and for protein or enzyme replacement therapy, and for treating neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treating metabolic disorders
ID: 11018966351